‘Left with 2-3 days’ vaccine stock for 45+ age group, health workers’

Atishi requests Central govt. to make more doses available

May 13, 2021 11:06 pm | Updated 11:06 pm IST - New Delhi

Aam Aadmi Party (AAP) leader Atishi on Thursday said the Capital was left with just two to three days’ stock of COVID-19 vaccine doses for those above 45 years of age as well as engaged in healthcare and front-line duties.

For those falling in the 18-44 age group, she said, Delhi had eight days’ stock of Covishield doses available. Over 41 lakh doses had been administered in the city so far and 74,448 people having been vaccinated in Delhi on Wednesday, she said.

“Delhi currently has three days of Covaxin and two days of Covishield stock for those above 45 years of age, healthcare and front-line workers. We request the government to make more doses available for this category,” she said.

40.29 lakh utilised

The Capital, Ms. Atishi said, had so far got 43.20 lakh doses for 45-plus citizens, healthcare and front-line workers of which 40.29 lakh had been utilised.

Delhi had received 8.17 lakh doses of vaccine doses for the 18-44 category of which 4.27 lakh had been utilised and the remaining doses, primarily Covishield, could last up to eight days, Ms. Atishi said.

This, she said, even as the city had already run out of Covaxin stock for the 18+ category and most of the centres administering the Bharat Biotech-manufactured vaccine had been temporarily shut till further orders.

“Dispensaries conduct routine immunisation of children on Wednesdays and Fridays. So, there were fewer vaccination centres on May 12,” she said.

41.64 lakh doses

According to the vaccine bulletin issued by the Delhi government on Thursday, a total number of 41.64 lakh doses had been administered to beneficiaries across all categories in the city since the inoculation drive began on January 16.

0 / 0
Sign in to unlock member-only benefits!
  • Access 10 free stories every month
  • Save stories to read later
  • Access to comment on every story
  • Sign-up/manage your newsletter subscriptions with a single click
  • Get notified by email for early access to discounts & offers on our products
Sign in

Comments

Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.

We have migrated to a new commenting platform. If you are already a registered user of The Hindu and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.